Catalysts for change
3 min read

ID&E Week is our annual opportunity to press pause and listen, learn and reflect. This year’s theme, “Catalysts for Change,” was also a call to action for Vertexians to ignite actionable change. Hear from Vice President Diana Cruz Solash on key takeaways from our sixth annual ID&E Week. 

The power of allyship
5 min read

We're celebrating our sixth annual ID&E Week at Vertex with the theme “Catalysts for Change.” Hear from Senior Vice President Ludovic Fenaux and our international Employee Resource Network (ERN) co-leads about the power of allyship and how we can all become catalysts for change. 

See inside. See cystic fibrosis
1 min read

Cystic fibrosis is a rare, genetic, progressive disease, in which symptoms and organ damage can manifest very early in life. These may not, however, be outwardly visible in all children and while some children can appear well on the outside, what is happening inside their bodies can tell a different story. 

Jonathan Biller

Executive Vice President and Chief Legal Officer
An image of Jonathan Biller, Executive Vice President and Chief Legal Officer at Vertex Pharmaceuticals

Jonathan Biller

Executive Vice President and Chief Legal Officer
An image of Jonathan Biller, Executive Vice President and Chief Legal Officer at Vertex Pharmaceuticals

Jonathan has deep legal, industry and business experience and expertise that will support our continued growth. He joined Vertex in 2022 and serves on the Executive Committee and oversees all aspects of our global legal and compliance functions. 

Her earned his bachelor’s degree in history from Brown University and his law degree from Yale Law School. Prior to Vertex, Jonathan served in several executive roles at Agios Pharmaceuticals, including Chief Legal Officer and most recently Chief Financial Officer and Head of Corporate Affairs. Prior to this, he served as Executive Vice President, General Counsel at Celgene, where he was responsible for its global legal function, and before that as Senior Vice President, Tax and Treasury. Prior to Celgene, he served in various leadership roles at Bunge Limited and Alcon, Inc. He began his legal career at Hopkins & Sutter, rising to the level of partner, and was also partner at Foley & Lardner after the firms merged. 

Jonathan has deep legal, industry and business experience and expertise that will support our continued growth. He joined Vertex in 2022 and serves on the Executive Committee and oversees all aspects of our global legal and compliance functions. 

Her earned his bachelor’s degree in history from Brown University and his law degree from Yale Law School. Prior to Vertex, Jonathan served in several executive roles at Agios Pharmaceuticals, including Chief Legal Officer and most recently Chief Financial Officer and Head of Corporate Affairs. Prior to this, he served as Executive Vice President, General Counsel at Celgene, where he was responsible for its global legal function, and before that as Senior Vice President, Tax and Treasury. Prior to Celgene, he served in various leadership roles at Bunge Limited and Alcon, Inc. He began his legal career at Hopkins & Sutter, rising to the level of partner, and was also partner at Foley & Lardner after the firms merged.